4 Geographic Atrophy Clinical Trials in Erie, PA (2026)

Q: How do I join a clinical trial in Erie?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Erie research site will contact you.

Recruiting Geographic Atrophy Studies in Erie

NCT07606365Recruiting

A Study in Adults With Geographic Atrophy

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD)....

Erie, PAPHASE2300 participantsSitala Bio LTD

View Study Details

NCT07441642Recruiting

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)....

Erie, PAPHASE2272 participantsNovartis Pharmaceuticals

View Study Details

NCT07419334Recruiting

Study of ALK-001 on the Progression of Stargardt Disease

This study evaluates the efficacy and safety of investigational study drug ALK-001 in participants 8 to 45 years of age, inclusive, with symptoms and signs of autosomal recessive Stargardt disease (ST...

Erie, PAPHASE3230 participantsAlkeus Pharmaceuticals, Inc.

View Study Details

NCT06765980Recruiting

A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

The goal of this study is to evaluate how safe and tolerable KRIYA-825 (VV-14295) is and to determine how effective it is in reducing the growth of geographic atrophy (GA) lesions in the treated eye i...

Erie, PAPHASE162 participantsKriya Therapeutics, Inc.

View Study Details

About Geographic Atrophy Clinical Trials in Erie

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 4 geographic atrophy clinical trials recruiting participants in Erie, PA. These studies are seeking a combined 864 participants. Research is being sponsored by Sitala Bio LTD, Novartis Pharmaceuticals, Alkeus Pharmaceuticals, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Erie — FAQ

Are there geographic atrophy clinical trials in Erie?

Yes, there are 4 geographic atrophy clinical trials currently recruiting in Erie, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Erie?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Erie research site will contact you about next steps.

Are clinical trials in Erie free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Erie studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 4 active trials in Erie are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 15, 2026 from ClinicalTrials.gov